
|Videos|July 13, 2016
Winson Y. Cheung on Managing Side Effects for Patients on Checkpoint Inhibitors
Author(s)Winson Y. Cheung, MD
Advertisement
Winson Y. Cheung, MD, Medical Oncologist at the British Columbia Cancer Agency in Vancouver, discusses the nurse’s role in managing side effects for patients who are on checkpoint inhibitors.
In a study of patients with metastatic melanoma who have taken checkpoint inhibitors, Cheung found that the vast majority of patients experienced side effects of varying degrees, the most common being diarrhea and skin rash. As checkpoint inhibitors continue to expand in use to treat other cancer types, it is important that nurses are aware of the side effects and know how to best manage them.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Camizestrant Approval: Nurses Key to New Breast Cancer Paradigm
2
FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care
3
Nursing Protocols for the New Oral RAS Inhibitor Daraxonrasib
4
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer
5



























































